150
Participants
Start Date
February 28, 2005
Primary Completion Date
April 30, 2007
Study Completion Date
April 30, 2007
rosiglitazone
6 months of treatment of blinded study drug
placebo
blinded treatment with matching placebo
University of Texas Southwestern Medical Center, Dallas
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Abbott RDx Cardiometabolic
OTHER
University of Texas Southwestern Medical Center
OTHER